Philip Hansten, PharmD

Polypharmacy is often a factor in the adverse events that elders experience.

Being aware of drugs that inhibit CYP2D6 is especially important for patients taking tamoxifen.

The second in a pair of articles on drug transporters, this article focuses on uptake transporters that actively pump drugs into cells.

Reducing the risk of adverse drug interactions requires taking various items into consideration, including possible outcomes.

Transporter proteins transport drugs in and out of cells and are susceptible to reduced or enhanced activity depending on drug exposure.